Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Lancet (London, England)|October 22, 1983
Purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas' disease)M Schechter, J E Flint, A Voller, et al.American Journal of Physical Anthropology|May 6, 1999
Isolation of Trypanosoma cruzi DNA in 4,000-year-old mummified human tissue from northern ChileF Guhl, C Jaramillo, G A Vallejo, et al.Journal of Clinical Microbiology|April 1, 1994
Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assayA Gonzalez-Ruiz, R Haque, T Rehman, et al.Journal of Clinical Pathology|March 1, 1994
Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolyticaA González-Ruiz, R Haque, A Aguirre, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 11, 2005
Molecular characterisation of Trypanosoma rangeli strains isolated from Rhodnius ecuadoriensis in Peru, R. colombiensis in Colombia and R. pallescens in Panama, supports a co-evolutionary association between parasites and vectorsD A Urrea, J C Carranza, C A Cuba Cuba, et al.Journal of Clinical Microbiology|November 1, 1992
A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolyticaA Gonzalez-Ruiz, R Haque, T Rehman, et al.Archives of Medical Research|January 1, 1992
Further diagnostic use of an invasive-specific monoclonal antibody against Entamoeba histolyticaA González-Ruíz, R Haque, T Rehman, et al.Biotechniques|February 24, 2001
Hybridization screening of very short PCR products for paleoepidemiological studies of Chagas' diseaseM Madden, W L Salo, J Streitz, et al.International Journal of Epidemiology|August 19, 2007
House-level risk factors for triatomine infestation in ColombiaD H Campbell-Lendrum, V M Angulo, L Esteban, et al.Antimicrobial Agents and Chemotherapy|November 20, 2013
Towards a paradigm shift in the treatment of chronic Chagas diseaseR Viotti, B Alarcón de Noya, T Araujo-Jorge, et al.Pageof 5